Incidence of Nonmelanoma Skin Cancer in Renal Transplant Recipients: A Systematic Review and Meta-analysis

Overview

Journal J Res Med Sci

Specialty General Medicine

Date 2018 Mar 14

PMID 29531566

Citations 10

Authors

Mohammad Matinfar

Shahrzad Shahidi

Awat Feizi

Affiliations

Soon will be listed here.

Abstract

Background: Nonmelanoma skin cancer (NMSC) in renal transplant recipients is common and associated with significant morbidity and mortality. The aim of the present systematic review and meta-analysis was to estimate the incidence of NMSC among renal transplant recipients.

Materials And Methods: We systematically searched PubMed, Medline, Scopus, and Web of Science databases for studies that assessed the incidence of NMSC in renal transplant recipients using a combination of relevant keywords. Two independent investigators included studies and extracted necessary information. Random effect meta-analysis was used to estimate pooled incidence of NMSC with 95% confidence intervals (CIs).

Results: Twenty-nine studies comprising 36,021 patients meet the criteria for the systematic review. The pooled incidence of NMSC in renal transplant recipients was 12.6% (95% CI: 12%-14%) with a majority of squamous cell carcinoma (SCC) 55% (95% CI: 47%-63%). The pooled estimate of the incidence rates of SCC and basal cell carcinoma was 2.7% (95% CI: 2%-3.4%) and 2.2% (95% CI: 1.5%-2.8%), respectively. Subgroup analysis per geographic location showed that pooled incidence of NMSC was 39.1% (95% CI: 26.3%-51.8%), 12.4% (95% CI: 8.8%-16%), and 1.2% (95% CI: 0.4%-2%) in Australia and New Zealand, Europe, and Middle East, respectively.

Conclusion: The results of the current meta-analysis demonstrated that the incidence of NMSC in renal transplant recipients varies widely. Regarding the high incidence of NMSC among renal transplant recipients, awareness of associated risk factors and early diagnosis of the malignancy in the population is a major clinical need.

Citing Articles

Basal Cell Carcinoma Arising in a Previous Full-Thickness Graft Donor Site: A Case Report and Comprehensive Literature Review.

Shen A, Seth I, Marcaccini G, Rozen W, Ross R J Clin Med. 2025; 14(2).

PMID: 39860596 PMC: 11766017. DOI: 10.3390/jcm14020591.

Polygenic scores and their applications in kidney disease.

Khan A, Kiryluk K Nat Rev Nephrol. 2024; 21(1):24-38.

PMID: 39271761 DOI: 10.1038/s41581-024-00886-2.

Therapeutic Approaches for Non-Melanoma Skin Cancer: Standard of Care and Emerging Modalities.

Sol S, Boncimino F, Todorova K, Waszyn S, Mandinova A Int J Mol Sci. 2024; 25(13).

PMID: 39000164 PMC: 11241167. DOI: 10.3390/ijms25137056.

A Review of Recent Advances in Computer-Aided Detection Methods Using Hyperspectral Imaging Engineering to Detect Skin Cancer.

Huang H, Hsiao Y, Karmakar R, Mukundan A, Chaudhary P, Hsieh S Cancers (Basel). 2023; 15(23).

PMID: 38067338 PMC: 10705122. DOI: 10.3390/cancers15235634.

Microbiome modulates immunotherapy response in cutaneous squamous cell carcinoma.

Voigt A, Walter A, Young T, Graham J, Batista Bittencourt B, Pulido A Exp Dermatol. 2023; 32(10):1624-1632.

PMID: 37350109 PMC: 10592435. DOI: 10.1111/exd.14864.

References

Lomas A, Leonardi-Bee J, Bath-Hextall F . A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012; 166(5):1069-80. DOI: 10.1111/j.1365-2133.2012.10830.x. View

Glover M, Bodmer J, Bodmer W, Kennedy L, Brown J, Navarrete C . HLA antigen frequencies in renal transplant recipients and non-immunosuppressed patients with non-melanoma skin cancer. Eur J Cancer. 1993; 29A(4):520-4. DOI: 10.1016/s0959-8049(05)80143-1. View

Keles Y, Tekin S, Duzenli M, Yuksel Y, Yucetin L, Dosemeci L . Post-transplantation Malignancy After Kidney Transplantation in Turkey. Transplant Proc. 2015; 47(5):1418-20. DOI: 10.1016/j.transproceed.2015.04.010. View

Moloney F, Almarzouqi E, OKelly P, Conlon P, Murphy G . Sunscreen use before and after transplantation and assessment of risk factors associated with skin cancer development in renal transplant recipients. Arch Dermatol. 2005; 141(8):978-82. DOI: 10.1001/archderm.141.8.978. View

Czarnecki D, Lewis A, Nicholson I, Tait B . Multiple nonmelanoma skin cancer associated with HLA DR7 in southern Australia. Cancer. 1991; 68(2):439-40. DOI: 10.1002/1097-0142(19910715)68:2<439::aid-cncr2820680238>3.0.co;2-l. View

Dantal J, Soulillou J . Immunosuppressive drugs and the risk of cancer after organ transplantation. N Engl J Med. 2005; 352(13):1371-3. DOI: 10.1056/NEJMe058018. View

Naldi L, Fortina A, Lovati S, Barba A, Gotti E, Tessari G . Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study. Transplantation. 2000; 70(10):1479-84. DOI: 10.1097/00007890-200011270-00015. View

Nyaga V, Arbyn M, Aerts M . Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health. 2015; 72(1):39. PMC: 4373114. DOI: 10.1186/2049-3258-72-39. View

Ng J, Cumming S, Leung V, Chong A . Accrual of non-melanoma skin cancer in renal-transplant recipients: experience of a Victorian tertiary referral institution. Australas J Dermatol. 2013; 55(1):43-8. DOI: 10.1111/ajd.12072. View

10.

Sterne J, Egger M, Smith G . Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ. 2001; 323(7304):101-5. PMC: 1120714. DOI: 10.1136/bmj.323.7304.101. View

11.

Pinho A, Gouveia M, Cardoso J, Xavier M, Vieira R, Alves R . Non-melanoma skin cancer in Portuguese kidney transplant recipients - incidence and risk factors. An Bras Dermatol. 2016; 91(4):455-62. PMC: 4999103. DOI: 10.1590/abd1806-4841.20164891. View

12.

Moosa M, Gralla J . Skin cancer in renal allograft recipients--experience in different ethnic groups residing in the same geographical region. Clin Transplant. 2005; 19(6):735-41. DOI: 10.1111/j.1399-0012.2005.00413.x. View

13.

Tessari G, Naldi L, Boschiero L, Nacchia F, Fior F, Forni A . Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study. Arch Dermatol. 2010; 146(3):294-9. DOI: 10.1001/archdermatol.2009.377. View

14.

Ho W, Murphy G . Update on the pathogenesis of post-transplant skin cancer in renal transplant recipients. Br J Dermatol. 2007; 158(2):217-24. DOI: 10.1111/j.1365-2133.2007.08363.x. View

15.

Higgins J, Thompson S, Deeks J, Altman D . Measuring inconsistency in meta-analyses. BMJ. 2003; 327(7414):557-60. PMC: 192859. DOI: 10.1136/bmj.327.7414.557. View

16.

Keller B, Braathen L, Marti H, Hunger R . Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern. Swiss Med Wkly. 2010; 140:w13036. DOI: 10.4414/smw.2010.13036. View

17.

Andres A . Cancer incidence after immunosuppressive treatment following kidney transplantation. Crit Rev Oncol Hematol. 2005; 56(1):71-85. DOI: 10.1016/j.critrevonc.2004.11.010. View

18.

Vrotniakaite K, Jaceviciute R, Rudminiene I, Laucyte-Cibulskiene A, Rainiene T, Jankevicius F . Malignancy after renal transplantation: a single-center experience. Ann Transplant. 2014; 19:456-63. DOI: 10.12659/AOT.890706. View

19.

Moloney F, Comber H, OLorcain P, OKelly P, Conlon P, Murphy G . A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol. 2006; 154(3):498-504. DOI: 10.1111/j.1365-2133.2005.07021.x. View

20.

Yunus M, Aziz T, Mubarak M . Posttransplant malignancies in renal transplant recipients: 22-years experience from a single center in Pakistan. Asian Pac J Cancer Prev. 2012; 13(2):575-8. DOI: 10.7314/apjcp.2012.13.2.575. View